Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04066829
Other study ID # HUM00159821
Secondary ID 1K08DA048110
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2019
Est. completion date July 31, 2021

Study information

Verified date October 2022
Source University of Michigan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will evaluate whether lowering the default number of doses for opioid prescriptions written in an electronic health record system can decrease opioid prescribing without causing unintended consequences such as worsened pain control.


Recruitment information / eligibility

Status Completed
Enrollment 198
Est. completion date July 31, 2021
Est. primary completion date July 31, 2021
Accepts healthy volunteers No
Gender All
Age group 12 Years to 25 Years
Eligibility Inclusion Criteria: - Adolescents and young adults aged 12-25 years undergoing tonsillectomy at C.S. Mott Hospital, University Hospital, Brighton Center for Specialty Care, or Livonia Center for Specialty Care from October 2019-July 2021, excluding April-May 2020 (owing to suspension of elective procedures due to COVID-19). - Surgeon belongs to the Department of Otolaryngology at the University of Michigan Medical School - Patients are not any of the following: patients living in foster care or with a legal guardian, patients with medical complexity or developmental delays, non-English speaking patients, patients with recent suicidal ideation documented in their chart, or patients undergoing emergent tonsillectomy. Exclusion Criteria: - Patients with prescription opioid use prior to surgery - Patients undergoing additional procedures at the same time as tonsillectomy (other than minor procedures such as tympanostomy tube placement) - Patients enrolled in another study - Patients who are not prescribed opioids post-operatively at discharge - Patients who are enrolled in the Michigan Pain-control Optimization Pathway (M-POP), which includes education about pain management and a small initial opioid prescription - Patients with hospitalization with length of stay > 1 day after surgery - Patients who decline to enroll - Additional exclusion criteria for secondary analysis: Patients who do not complete the baseline and post-operative day 14 surveys

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Default setting intervention
The new default settings will be implemented only for patients in the experimental arm.

Locations

Country Name City State
United States The University of Michigan Ann Arbor Michigan

Sponsors (2)

Lead Sponsor Collaborator
University of Michigan National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Doses in the Initial Discharge Opioid Prescription Doses are defined as the maximum number of instances a patient could take opioids if they took them as prescribed. Number of doses are calculated from the electronic health record. Day of discharge, approximately 1 day
Primary Proportion of Patients for Whom the Number of Doses in the Discharge Opioid Prescription Equals the Number of Doses in the New Default Settings The new default settings called for 12 doses in the discharge prescription.
This measure assesses the proportion of participants with 12 doses in the discharge prescription, regardless of which arm they were in.
Doses are defined as the maximum number of instances a patient could take opioids if they took them as prescribed. Number of doses are calculated from the electronic health record.
Day of discharge, approximately 1 day
Primary Proportion of Participants Who Had at Least One Opioid Prescription Refill From University of Michigan During the Two Weeks After Surgery Doses are defined as the maximum number of instances a patient could take opioids if they took them as prescribed. Number of doses are calculated from the electronic health record. Day 14
Primary Proportion of Patients Who Visited or Saw a University of Michigan Provider Due to Pain During the Two Weeks After Surgery Detailed in electronic health record. Excludes emergency department visits and hospitalizations for pain. Day 14
Primary Proportion of Patients With at Least One Emergency Department and/or Hospitalization at University of Michigan for Pain During the Two Weeks After Surgery Detailed in electronic health record Day 14
Secondary Overall Satisfaction Score on Pain Control During the Two Weeks After Surgery as Measured by the Post-operative Survey. Participants were surveyed on Day 14 and asked to report level of satisfaction with pain control since their surgery.
Pain control satisfaction is on a scale of 1-10 with higher scores indicating higher satisfaction
Day 14
Secondary Proportion of Patients Who Reported That Their Pain Was Well-controlled as Measured by the Post-operative Survey. Day 14
Secondary Proportion of Patients Whose Overall Pain Control Was Rated as Much Worse or Worse Than Expected as Measured by the Post-operative Survey. Survey was comprised of 5 options:
Much worse than you expected
Worse than you expected
About what you expected
Better than you expected
Much better than you expected
Day 14
Secondary Proportion of Patients Whose Pain Has Resolved by Day 14 After Surgery as Measured by the Post-operative Survey. Survey asked participant on what day pain had resolved. If participants indicated pain had resolved by Day 14, then they were coded as 1, and 0 otherwise. Day 14
Secondary Pain in the Throat and/or Mouth Over the Past 7 Days at Its Worst as Measured by the Post-operative Survey. Pain control is on a scale of 0-10 with higher scores indicating more pain. Day 14
Secondary Pain in the Throat and/or Mouth Over the Past 7 Days on Average as Measured by the Post-operative Survey. Pain control is on a scale of 0-10 with higher scores indicating worse pain. Day 14
Secondary Proportion of Patients With Leftover Doses of Opioids as Measured by the Post-operative Survey. Participants who answered 'No' to the following question: Did you take all of the opioid pain medications that were prescribed to you during the two weeks after surgery? Day 14
Secondary Number of Opioid Doses Taken During the Two Weeks After Surgery as Measured by the Post-operative Survey. Patients were asked to report the number of instances in which they used opioids prescribed to them. Day 14
Secondary Proportion of Patients Who Misused Opioids Prescribed to Others at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey. Includes any use of opioids prescribed to others Day 14
Secondary Proportion of Patients Who Misused Opioids Prescribed to Them at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey. Includes taking one's own opioids in greater amounts, more often, or longer than directed by a doctor. Day 14
Secondary Patient Health Questionnaire 8-item (PHQ-8) Score (Depression) as Measured by the Post-operative Survey. This is an 8-item self-report scale, all items are rated on a score of 0-3, for a total range of 0-24. Higher scores indicate more depressive symptoms Day 14
Secondary Patient-Reported Outcomes Measurement Information System (PROMIS)- Pediatric Anxiety - Short Form 8a Score as Measured by the Post-operative Survey. This measure is 8 items each scored from 1 to 5 points, with the lowest possible raw score being 8 and the highest possible raw score being 40. Higher scores indicate greater anxiety, Day 14
Secondary Patient-Reported Outcomes Measurement Information System (PROMIS)- Sleep Disturbance - Short Form 4a Score as Measured by the Post-operative Survey. This measure is 4 items each scored from 1 to 5 points, with the lowest possible raw score being 8 and the highest possible raw score being 40. Higher scores indicate greater sleep disturbance, i.e. worse sleep. Day 14
Secondary Proportion of Patients Who Saw Their Primary Care Doctor (or a Colleague) in the Office Due to Pain at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey. Day 14
Secondary Proportion of Patients Who Visited a Retail Clinic Due to Pain at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey. Day 14
Secondary Proportion of Patients Who Visited an Urgent Care Center Due to Pain at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey. Day 14
Secondary Proportion of Patients Who Visited an Emergency Department and/or Were Hospitalized Due to Poorly Controlled Pain at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey. Day 14
Secondary Proportion of Patients With Leftover Doses Who Disposed of Them Proportion of patients with leftover doses who disposed of them 14 Days
See also
  Status Clinical Trial Phase
Completed NCT03266094 - A Study of BiZactâ„¢ on Children and Adolescents Undergoing Tonsillectomy N/A
Completed NCT02228135 - The Effect of Dexamethasone Dosing on Post-tonsillectomy Hemorrhage N/A
Completed NCT00662987 - Effect of Duration of Antibiotic Therapy on Recovery Following Tonsillectomy N/A
Completed NCT00273754 - The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA). Phase 2
Recruiting NCT06122948 - Effect of Intranasal Midazolam Versus Ketamine Midazolam Combination as a Premedication on the Occurrence of Postoperative Respiratory Adverse Events Phase 3
Recruiting NCT03783182 - Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy Phase 4
Completed NCT03793816 - Tonsillectomy Using BiZactâ„¢ - a Randomized Side-controlled Clinical Trial N/A
Not yet recruiting NCT06359925 - Suprazygomatic Nerve Block in Tonsillectomy Patients N/A
Recruiting NCT06079125 - PFDD Versus PFDRT in Chiari Decompression Surgery N/A
Recruiting NCT01904461 - HemORL: Monocentric, Prospective, Comparative Study on the Use of a Haemostatic Vacuum Device During Tonsillectomy in Children N/A
Not yet recruiting NCT00756873 - Etoricoxib in Ear Nose Throat Surgery Phase 3
Recruiting NCT05600595 - The Evaluation of Eustachian Tube Function and Its Influencing Factors After Snoring Operation in Children
Completed NCT02987985 - Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy Phase 3
Recruiting NCT05158348 - A Comparative Study to Measure the Effect of Nebulized Dexmedetomidine Phase 3
Completed NCT01605903 - Postoperative Ibuprofen and the Risk of Bleeding After Tonsillectomy With or Without Adenoidectomy Phase 2
Enrolling by invitation NCT02444533 - EXPAREL® for Pain After Tonsillectomy Phase 4
Recruiting NCT02829515 - Tonsil Surgery in Sweden: A National Quality Register
Not yet recruiting NCT03491085 - Role of Antibiotics Post Tonsillectomy Phase 1/Phase 2
Recruiting NCT05270109 - Cold Steel Versus "Hot" BiZact Tonsillectomy; Comparing Post Tonsillectomy Morbidity N/A
Recruiting NCT05161754 - Tonsillectomy and Risk of Post-Tonsillectomy Hemorrhage N/A